Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
16163
CAS Number:
1423017-87-1
N α -1-(4,4-diméthyl-2,6-dioxocyclohex-1-ylidène)éthyl- N δ -Fmoc-L-ornitine
Purity:
≥ 99 % (dosage par titration, HPLC, CCM)
Synonym(s):
Dde-L-Orn(Fmoc)-OH
Documents
$127.79 /250 mg
Taille
Request Bulk Quote
Informations sur le produit

Na-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-Nd-Fmoc-L-ornitine is a specialized amino acid derivative that plays a crucial role in peptide synthesis and drug development. This compound is particularly valued for its unique structural features, which enhance the stability and bioactivity of peptides. Its Fmoc (9-fluorenylmethoxycarbonyl) protecting group allows for easy incorporation into solid-phase peptide synthesis, making it an ideal choice for researchers focused on developing novel therapeutic peptides. The compound's cyclohexenylidene moiety contributes to its ability to form stable conjugates, which can be beneficial in targeted drug delivery systems.

In addition to its applications in peptide synthesis, Na-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-Nd-Fmoc-L-ornitine has potential uses in the development of biomaterials and as a building block for complex organic molecules. Its unique properties make it a valuable asset in pharmaceutical research, particularly in the design of compounds with enhanced efficacy and reduced side effects. Researchers and industry professionals can leverage this compound to explore innovative solutions in drug formulation and delivery.

Numéro CAS 
1423017-87-1
Formule moléculaire
C30H34N2O6
Poids moléculaire 
518.6
Point de fusion 
138 - 143 °C
Rotation optique 
[a] D 20 = -11 ± 2º (C=1 dans MeOH)
Informations générales
Numéro CAS 
1423017-87-1
Formule moléculaire
C30H34N2O6
Poids moléculaire 
518.6
Point de fusion 
138 - 143 °C
Rotation optique 
[a] D 20 = -11 ± 2º (C=1 dans MeOH)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Na-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-Nd-Fmoc-L-ornitine is widely utilized in research focused on

  • Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, which are essential for developing new drugs and therapies.
  • Drug Development: Its unique structure allows for the design of novel pharmaceuticals, particularly in targeting specific biological pathways, enhancing efficacy and reducing side effects.
  • Bioconjugation: It is used in bioconjugation processes to attach biomolecules to drugs, improving delivery mechanisms and therapeutic outcomes in targeted therapies.
  • Research in Cancer Therapeutics: The compound is explored for its potential in cancer treatment, as it can be modified to create compounds that selectively target cancer cells.
  • Biomaterials: Its properties make it suitable for developing biomaterials that can be used in tissue engineering and regenerative medicine, providing scaffolds that support cell growth.

Citations